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The knowledge on the status of several biomarkers [1] is a useful tool for disease clinical characterization and treatment of type 2 diabetes. The additive clinical effect of the presence of different biomarkers can be used to evaluate the risk to develop angiopathy and also in disease management.
A population-based case-control study in 150 Portuguese type 2 diabetic patients was performed. Group I -75 diabetics with angiopathy, group II -75 diabetics without angiopathy and group IIInon-diabetic controls. Plasma levels of homocysteine, cysteine, malondialdehyde (MAD), vitamins B 6 , C, A and E and carotenoids were measured by HPLC methods. Vitamin B 12 and folate serum levels were achieved by an electrochemiluminescence method.
The aim of this study was to evaluate the levels of cardiovascular, oxidative stress and nutritional biomarkers and their relationship with the presence of type 2 diabetes and angiopathy.
The baseline characteristics of diabetic patients studied are presented in Table 1 . The results of biomarkers plasma or serum levels evaluation are presented in Table 2 . The hyperhomocysteinemia prevalence was 20% (group I), 8.7% (group II) and 0.71% (group III). Group I showed the higher prevalence of hypercysteinemia (17%). The MAD serum levels were above the reference value for all groups. The percentage of subjects with ascorbic acid low plasma levels were statistically different in diabetic (I: 55%; II: 47%) compared to non-diabetic subjects (III: 22%). The prevalence of hypovitaminosis B 6 deficiency was at least 30% for all groups. Type 2 diabetes predisposes to hypovitaminosis C (OR: 3.10; p = 0.0002) ( Table 3) . In group I, the probability to have hyperhomocysteinemia was around 3 times higher (p = 0.04) in comparison with group II and 35 times (p = 0.0006) with group III ( Table 4 ). The combined effect of type 2 diabetes and angiopathy is associated with high MAD (OR: 5.33; p = 0.002) serum levels compared to group III ( Table 5 ). The effect of the angiopathy presence was only significant for homocysteine biomarker ( Table 5) . Table 1 -Baseline characteristics of the study population. Table 2 -Evaluation of plasma or serum levels of biomarkers. Table 3 -Effect of type 2 diabetes presence on the variation of biomarkers. Table 5 -Combined effect of type 2 diabetes and angiopathy presence on the variation of biomarkers. Table 4 -Effect of angiopathy presence on the variation of biomarkers.
View publication stats View publication stats
